Key facts
- Notable investors include Antler, Toubkal Partners.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Gala GLP-1
- ·The full record, as it builds
Funding rounds
No funding rounds for Gala GLP-1 are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gala GLP-1
Developer of a weight management platform designed to assist individuals with significant weight loss. The company's platform features personalized treatment plans, medical supervision, digital progress tracking, and transparent pricing, enabling adults seeking effective weight reduction to access clinically guided therapies and manage their health goals conveniently and confidently.
- Sector
- Healthcare
- HQ
- Wilmington, DE, United States
- Founded
- 2023
- Website
- galaglp1.com/
- Ownership
- Privately Held (backing)
Gala GLP-1 doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gala GLP-1 shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gala GLP-1 in its N-PORT filings yet. We sweep new filings monthly.